Investing.com - Financial Markets Worldwide

NgeneBio Co Ltd (354200)

KOSDAQ
Currency in KRW
1,799
-46(-2.49%)
Delayed Data·
354200 Scorecard
Full Analysis
Quickly burning through cash
354200 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
1,7891,850
52 wk Range
1,5034,696
Key Statistics
Edit
Bid/Ask
1,793.00 / 1,799.00
Prev. Close
1,845
Open
1,850
Day's Range
1,789-1,850
52 wk Range
1,503-4,696
Volume
26.15K
Average Volume (3m)
210.44K
1-Year Change
-34.74%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
354200 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 8
Prominent player in the Biotechnology industry
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

NgeneBio Co Ltd Company Profile

NGeneBio Co., Ltd. develops in vitro diagnostics companion diagnostics products and bioinformatics software. It offers BRCAaccuTest and BRCAaccuTest PLUS are reagent kits for breast and ovarian cancer, and hereditary breast and ovarian cancer syndrome; HEMEaccuTest, a clinical NGS kit for hematological malignancies, such as acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic/myeloproliferative neoplasm, multiple myeloma, and lymphoma; SOLIDaccuTest, a genetic variants screening for solid tumors; HLAaccuTest, an in vitro diagnostic medical device for human leukocyte antigen typing; and OncoaccuPanel, a solid tumor oncology next generation sequencing test. The company also provides NGeneAnalySys, a software for analysis of the genetic testing data; and EasyHLAanalyzer, which offers the HLA typing identifing human leukocyte antigen for histocompatibility antigens using data from NGS. In addition, it offers IDaccuTest, a short tandem repeat test for family relationship testing, identity testing, forensics, and chimerism analysis; and NGenePlex nCoV qRT-PCR Kit, a reagent of real-time reverse transcription-polymerase chain reaction assay intended for the qualitatively detecting nucleic acid of SARS-CoV-2 from patients infected or suspected of COVID-19. The company was founded in 2015 and is headquartered in Seoul, South Korea.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
58
Market
South Korea

Compare 354200 to Peers and Sector

Metrics to compare
354200
Peers
Sector
Relationship
P/E Ratio
−3.8x−5.6x−0.5x
PEG Ratio
−0.64−0.030.00
Price/Book
3.2x2.1x2.6x
Price / LTM Sales
6.7x6.0x3.2x
Upside (Analyst Target)
-0.0%43.8%
Fair Value Upside
Unlock12.7%8.1%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-138.00 / --
Revenue / Forecast
2.04B / --
EPS Revisions
a
a
Unlock
Last 90 days

354200 Income Statement

FAQ

What Stock Exchange Does NgeneBio Co Trade On?

NgeneBio Co is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for NgeneBio Co?

The stock symbol for NgeneBio Co is "354200."

What Is the NgeneBio Co Market Cap?

As of today, NgeneBio Co market cap is 46.20B.

What Is NgeneBio Co's Earnings Per Share (TTM)?

The NgeneBio Co EPS (TTM) is -766.58.

From a Technical Analysis Perspective, Is 354200 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has NgeneBio Co Stock Split?

NgeneBio Co has split 0 times.

How Many Employees Does NgeneBio Co Have?

NgeneBio Co has 58 employees.

What is the current trading status of NgeneBio Co (354200)?

As of 31 Jul 2025, NgeneBio Co (354200) is trading at a price of 1,799.00, with a previous close of 1,845.00. The stock has fluctuated within a day range of 1,789.00 to 1,850.00, while its 52-week range spans from 1,503.00 to 4,696.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.